ACCESS-AD launches survey to identify local barriers to Alzheimer’s disease care

29/10/2026

The IHI-funded ACCESS-AD project has launched a new survey to better understand local barriers to the implementation of Alzheimer’s disease (AD) diagnostic and treatment pathways across Europe.

The survey was officially launched at the Alzheimer Europe Conference in Dublin on 29 October, during an oral presentation by Gaby Marquardt (Siemens Healthineers), entitled “ACCESS-AD: A pan-European initiative to advance equitable implementation of Alzheimer’s disease diagnostics and therapies”. Her presentation introduced the project, outlining its overall ambition, key objectives and consortium.

As part of the ACCESS-AD project, the survey aims to better understand how AD diagnostic and treatment pathways are currently organised across different healthcare settings. The findings will help identify local needs, implementation challenges and opportunities to improve care pathways and support future deployment of disease-modifying therapies and digital solutions.

The survey will remain open until 31 December 2026. Take part in the survey: https://redcap.ki.se/surveys/?s=MKCFR8833M9HHNEM 
 

Зображення